These data show that common prostate cancer cell lines reflect the same pattern of increased BRG1 protein that is observed in prostate tumours compared to normal prostate samples and therefore provides an appropriate model system to explore the functional consequences of BRG1 dysregulation on the transcriptome. Here, SMARCA4 is linked to prostate carcinoma.